非西班牙裔黑人与白人宫颈癌患者的生存差异因组织学类型而异,且很大程度上可由可改变因素解释
研究纳入2004至2017年美国国家癌症数据库中10111例黑人及43252例白人I-IV期宫颈癌患者,比较生存差异。黑人患者总体生存更差(HR=1.40,95%CI=1.35-1.45),差异因组织学而异:鳞癌HR=1.20(95%CI=1.15-1.24),腺癌HR=2.32(95%CI=2.12-2.54),交互作用P<0.0001。倾向评分加权平衡人口学、社会经济和临床因素后,鳞癌(AHR=1.01,95%CI=0.97-1.06)与腺癌(AHR=1.09,95%CI=0.96-1.24)均不再有差异。
要点
- 黑人宫颈癌患者生存差于白人(HR=1.40,95%CI=1.35-1.45)
- 生存差异因组织学而异:鳞癌HR=1.20,腺癌HR=2.32(交互作用P<0.0001)
- 平衡可改变因素后鳞癌与腺癌的种族生存差异均不再显著
核心结论
- 黑人宫颈癌患者生存差于白人,差异因组织学类型而异,且很大程度上可由可改变因素解释。
研究设计与样本
- 基于美国国家癌症数据库的队列研究,纳入2004至2017年诊断的I-IV期宫颈癌非西班牙裔黑人与非西班牙裔白人患者,共10111例黑人和43252例白人。
- 采用Cox模型估计风险比(HR)或校正风险比(AHR)及95%置信区间(CI)。
- 在鳞状细胞癌(SCC)或腺癌(AC)患者中应用倾向评分加权,估计人口学、社会经济和临床因素对黑人 vs 白人生存差异的贡献。
主要发现
- 黑人宫颈癌患者生存差于白人(HR=1.40,95%CI=1.35-1.45)。
- 黑人 vs 白人生存差异因组织学显著不同:SCC为HR=1.20(95%CI=1.15-1.24),AC为HR=2.32(95%CI=2.12-2.54),交互作用P<0.0001。
- 平衡所选人口学、社会经济和临床因素后,SCC患者黑人 vs 白人不再有生存差异(AHR=1.01,95%CI=0.97-1.06),AC患者亦不再有差异(AHR=1.09,95%CI=0.96-1.24)。
- SCC中,对生存差异贡献最大的是社区收入和保险;AC中,年龄贡献最大,其次为社区收入、保险和分期。
- AC(而非SCC)在≥65岁诊断在黑人与白人患者中更常见(黑人26% vs 白人13%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated racial disparities in survival by histology in cervical cancer and examined the factors contributing to these disparities. METHODS: Non-Hispanic Black and non-Hispanic White (hereafter known as Black and White) patients with stage I-IV cervical carcinoma diagnosed between 2004 and 2017 in the National Cancer Database were studied. Survival differences were compared using Cox modeling to estimate hazard ratio (HR) or adjusted HR (AHR) and 95% confidence interval (CI). The contribution of demographic, socioeconomic and clinical factors to the Black vs White differences in survival was estimated after applying propensity score weighting in patients with squamous cell carcinoma (SCC) or adenocarcinoma (AC). RESULTS: This study included 10,111 Black and 43,252 White patients with cervical cancer. Black patients had worse survival than White cervical cancer patients (HR = 1.40, 95% CI = 1.35-1.45). Survival disparities between Black and White patients varied significantly by histology (HR = 1.20, 95% CI = 1.15-1.24 for SCC; HR = 2.32, 95% CI = 2.12-2.54 for AC, interaction p < 0.0001). After balancing the selected demographic, socioeconomic and clinical factors, survival in Black vs. White patients was no longer different in those with SCC (AHR = 1.01, 95% CI 0.97-1.06) or AC (AHR = 1.09, 95% CI = 0.96-1.24). In SCC, the largest contributors to survival disparities were neighborhood income and insurance. In AC, age was the most significant contributor followed by neighborhood income, insurance, and stage. Diagnosis of AC (but not SCC) at ≥65 years old was more common in Black vs. White patients (26% vs. 13%, respectively). CONCLUSIONS: Histology matters in survival disparities and diagnosis at ≥65 years old between Black and White cervical cancer patients. These disparities were largely explained by modifiable factors.
引用
- Kucera CW, Chappell NP, Tian C, et al. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecol Oncol. 2024. PMID: 38340648. doi:10.1016/j.ygyno.2024.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。